Compare COF & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COF | BDX |
|---|---|---|
| Founded | 1988 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.2B | 43.0B |
| IPO Year | 2008 | 1998 |
| Metric | COF | BDX |
|---|---|---|
| Price | $214.97 | $179.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $258.94 | $186.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | 1.68% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.34 | 1.59 |
| Revenue | ★ $53,434,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $95.92 | N/A |
| Revenue Next Year | $4.90 | $3.02 |
| P/E Ratio | ★ $65.75 | $116.19 |
| Revenue Growth | ★ 36.62 | 8.24 |
| 52 Week Low | $174.24 | $140.11 |
| 52 Week High | $259.64 | $213.08 |
| Indicator | COF | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 48.57 |
| Support Level | $212.94 | $141.69 |
| Resistance Level | $226.49 | $187.35 |
| Average True Range (ATR) | 4.57 | 3.88 |
| MACD | -0.62 | -1.76 |
| Stochastic Oscillator | 30.66 | 13.15 |
Capital One Financial is a diversified financial-services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending provides the majority of the bank's revenue.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.